维昇药业 funding history / development milestones

IPO上市,

2025.03.01,

基石轮,3100万美元

2025.02.01, 安科生物

A轮,融资金额未公开

Note: collected from public online reports, for reference only.

People who follow 维昇药业 also follow

维昇药业 Competitors (Similar Companies)

“专注于碳纳米管及其相关产品的研发定制”
“致力于提高动物采食量和消化能力”
“Power electronics energy conversion and control”
电子厂/电子 触摸屏 触摸显示器 触控
PCBA CABLE 精密连接器 连接器
广告 媒体 文化传媒 营销服务
“Focusing on environmental control for data centers and equipment”
“To produce more affordable and effective medicines for the Chinese peo”
“Make it easy to do business anywhere”
“Committed to improving medical quality”
生产 煤电 超低排放 火电
“Focusing on the pharmaceutical and health industry”
“High-end medical device group”
“A leading enterprise in minimally invasive interventional medical devi”
内燃机 动力总成 柴油机 发动机